Skip to content
Events

Details

Illumina will be supporting the Nordics Network for Fetal Medicine (NNFM) annual meeting, which will take place from May 3rd - May 5th in Stockholm, Sweden. As part of our HCP Demand Generation strategy, we aim to extend our reach to the local leading professional society in the Nordics region. At the event, one of our esteemed colleagues Kristin Dalton, Genetic Counsellor and Senior Medical Affairs Manager will be presenting at an Illumina sponsored workshop on Non-invasive prenatal testing, what matters most to expectant parents? Patient preferences and educational tools.
Date & Time
3 May 2022 – 5 May 2022
Location
Stockholm
Sweden
Europe
Topic
Reproductive health
This event has passed
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.